Series of strains of Streptococcus faecium ATCC 8043, Lactobacillus casei ATCC 7469, and Pediococcus cerevisiae ATCC 8081 with increasing resistance to the active antifolate antimalarial drugs chlorguanide triazine (CGT), pyrimethamine (PM), and trimethoprim (TMP) were isolated. These mutant strains, stable for at least 3 to 5 years, were examined for cross-resistance and collateral susceptibility to the above compounds and to methotrexate (MTX). Generally, they exhibited crossresistance to all four compounds, but resistance of a strain to one compound did not predict accurately its resistance to another drug. Unexpectedly, L. casei resistant to CGT exhibited collateral susceptibility to MTX, TMP, and PM varying from 5-to 20-fold. P. cerevisiae developed resistance to CGT readily but maintained its susceptibility to PM and TMP after prolonged exposure to these compounds. Resistance to these antimalarial antifolates was accompanied by only lowgrade cross-resistance to MTX, a representative antileukemic antifolate agent.
The emergence of strains of Plasmodium falciparum malaria parasites resistant to chloroquine, a drug long regarded as free from this liability, made it important to find new active agents. Folic acid antagonists, which constitute another type of antimalarial, particularly in combination with a sulfonamide, are active against some of these chloroquine-resistant strains (13, 15) . Therefore, as part of a national program, we have been testing new synthetic compounds for antifolate activity using bacteria that require preformed folates for growth.
It is well recognized that malarial parasites frequently develop resistance to active antifolate agents (15, 20) . Furthermore, because of the general structural similarities of these compounds, cross-resistance to other antifolates has been a frequent but not invariable finding both in malarial parasites (1, 13, 14, 16) and in bacteria (9, 17) . The conclusion has been drawn that resistance to this type of compound is due to a multiplicity of mechanisms (8, 9) .
With the hope of separating some of the factors determining antifolate resistance, we have isolated strains of folate-requiring bacteria at various time intervals during exposure of the cultures to chlorguanide triazine (CGT), the active me- ' Contribution no. 1069 from the Army Research Program on malaria. Presented in part at the annual meeting of the Federation of American Societies for Experimental Biology, Atlantic City, N.J., 13-18 April 1969. tabolite of chlorguanide, pyrimethamine (PM), and trimethoprim (TMP). The development of these strains and their patterns of cross-resistance and collateral susceptibility are the subject of this report. The resistant strains were also tested against methotrexate (MTX) to determine whether the pattern of response extends to folate analogues which are relatively inactive in malaria but are active in the therapy of leukemia. faecium and L. casei and 200 to 250 for P. cerevisiae; these readings represented approximately 2 X 108 to 3 X 108 cells per ml for S. faecium and P. cerevisiae and 9 X 108 cells per ml for L. casei as determined by plate count. Subinoculations into drug-free medium were made from tubes showing approximately 50% of control growth. These cultures were incubated for 16 to 18 hr, washed, and resuspended in saline to prepare the standardized inocula for the next series of tubes. In this way, it was possible to determine accurately the concentration of compound needed to cause 50% growth inhibition (IC50) of a strain at each passage.
MATERIALS AND METHODS
Two or three transfers were made each week in drug-containing medium. On Friday of each week, the culture was passaged to yeast extract or yeast extractpeptone-agar (see above), incubated for 24 hr, and refrigerated over the weekend. This preparation was used as the source of inoculum at the beginning of the next week. Cultures selected at various intervals were retained. They have been designated by the compound to which they were exposed and in order of isolation, e.g., CGTr-A, CGTr-B .... CGTr-H. These isolates were maintained by monthly transfer in drug-free agar and were used to determine cross-reactions to the other compounds.
RESULTS
The concentrations of CGT, PM, TMP, and MTX needed to produce 50%O inhibition of growth of the parent susceptible strains of S. faecium, L. casei, and P. cerevisiae are given in Table 1 . The relative activities of the compounds against these parent strains may be summarized as follows: S. faecium, MTX > PM > CGT > TMP; L. casei, MTX > TMP > PM > CGT; P. cerevisiae, MTX > PM > TMP > CGT. In each case, MTX was the most active compound. PM was always more active than CGT, whereas TMP changed position for each organism.
The patterns of response obtained when S. faecium was exposed to increasing concentrations of CGT, PM, or TMP are shown in Fig. 1 . It can be seen that resistance to CGT developed very rapidly; thus, strain CGTr-H isolated after only 26 passages was 192,000 times as resistant to CGT as the parent strain. The CGT-resistant isolates showed increased resistance to PM, but the ratios of CGT resistance to PM resistance were not in the same proportion for the different strains. Cross-resistance to TMP in the CGTresistant strains was unexpectedly low, reaching only 16-fold. Resistance to MTX was even lower, being only sixfold.
The development of resistance of S. faecium to PM followed a very different pattern. Resistance developed slowly in a stepwise manner so that at the end of 74 passages the PMr-F strain was 13,500 times as resistant as the parent strain. There was pronounced cross-resistance to CGT, but the ratio of CGT resistance to PM resistance for the PMr-F strain was only 5 whereas the same ratio for CGTr-H was 150. Resistance to TMP increased with PM resistance, but the maximal increase was only 150-fold. The most resistant strain, PMr-F, showed a 33-fold increase in resistance to MTX.
Development of resistance of S. faecium to TMP resembled the pattern observed with PM in that there were stepwise increases in resistance followed by long intervals without change. The TMP resistance of TMPr-G was 460 times that of the parent strain, whereas its CGT and PM resistance were 80-and 75-fold, respectively. The highest resistance to MTX in the TMP-resistant organisms was sevenfold. The development of resistance by P. cerevisiae to CGT is shown in Fig. 3 . Resistance to CGT developed easily, but the increase in resistance (26-fold) was limited by the low susceptibility of the parent strain and the solubility of the drug in the medium. Only a three-to sixfold cross-resistance developed to PM, TMP, and MTX.
Although P. cerevisiae was transferred 65 times in medium containing PM and 40 times in TMP, no significant changes in susceptibility to either compound were detected (Fig. 3) .
The resistant strains for all three organisms have been retested at approximately 6 (4,6-diamino-1-[3',4 '-dichlorophenyl]-1, 2-dihydro-2, 2-dimethyl-s-triazine HCI) which were cross-resistant to a number of dihydrotriazines but exhibited no cross-resistance to 2 ,4-diamino-pyrimidines (such as PM) or to aminopterin or MTX. Singer et al. (17) isolated strains of L. casei resistant to PM that were cross-resistant to all of the folic acid antagonists tested, including representative diaminoquinazolines, pyridopyrimidines, pteridines, and benzyl-and phenylpyrimidines. The same workers also reported that strains of Proteus vulgaris resistant to 2,4-diamino-5-(3',4'-dimethoxybenzyl) pyrimidine were cross-resistant to benzylphenoxyand pyridopyrimidines; they were as susceptible as the wild strain to PM and a quinazoline.
Nichol (12) reported that a strain of P. cerevisiae selected for its ability to grow in folic acid medium was more susceptible than the parent strain to structural analogues of folic acid such as aminopterin and amethopterin but showed no change in susceptibility to PM. Burchenal and co-workers (2) reported a strain of S. faecium resistant to 2, 4-diamino-5-(3', 4'-dichlorophenyl)-6-methylpyrimidine (DDMP) which was crossresistant to MTX. Although bacteria resistant to MTX or aminopterin have been studied extensively (9), few of these strains have been examined for their resistance patterns to the typical antimalarial or antibacterial antifolate compounds. An MTX-resistant strain of Escherichia coli has been reported to be cross-resistant to PM (F. M. With few exceptions, the previous studies have been concerned only with the organisms at the most resistant point, permitting no insight into the nature or complexity of the development of resistance patterns. Therefore, in the present studies we examined not only the final most resistant strains but also representative strains isolated and preserved at various stages during the elaboration of resistance. The results of these studies warrant certain conclusions.
(i) Development of resistance to antimalarial antifolate agents in these bacteria appears to comprise a number of discrete steps. These occur rather unpredictably in time but lead to the formation of a series of stable mutant strains with unchanging characteristics. These variants of intermediate resistance as well as the most highly nonsusceptible forms have exhibited consistently the same patterns of resistance, cross-resistance, and collateral susceptibility observed when they were first isolated 3 to 5 years ago.
( The combined effects of all of these changes do not appear to account for the total drug resistance exhibited by these organisms. Further studies on the growth requirements and on biochemical differences in these strains are in progress. It is our hope that by analyzing the biochemical changes as one moves from one intermediate strain to the next and finally to the most resistant strains we will be able to account for the total fold increase in resistance. Study of the changes in the P. cerevisiae strain resistant to CGT may make it possible to explain why this organism readily develops resistance to CGT but shows no significant change in susceptibility to PM or TMP after prolonged exposure to these latter agents.
